SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-19-008005
Filing Date
2019-12-26
Accepted
2019-12-26 18:15:06
Documents
1
Period of Report
2019-12-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-47018.html 4  
1 PRIMARY DOCUMENT marketforms-47018.xml 4 12725
  Complete submission text file 0001214659-19-008005.txt   14157
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O MIRATI THERAPEUTICS, INC. 9393 TOWNE CENTRE DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address
Christensen Jamie (Reporting) CIK: 0001599324 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 191311346